ArticleCancer control : journal of the Moffitt Cancer Center
BRCA1 rs799917 and rs1799966 Variants and Breast Cancer Risk in Nigerian Women: A Case-Control Study With Population-Based Allele Frequency Analysis.
Article in Cancer control : journal of the Moffitt Cancer Center. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
26 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
IntroductionBRCA1 is a tumor suppressor gene involved in DNA repair, genomic stability, and cell cycle regulation. The BRCA1 single nucleotide polymorphisms (SNPs) rs799917 and rs1799966 have been widely investigated for their association with breast cancer (BCa) risk, with inconsistent and population-specific findings. However, their frequency and clinical relevance in Nigerian populations remain poorly characterized. This study evaluated their association with BCa risk in Nigerian women and interpreted these findings within a global context of allele frequency variation.MethodsThis prospective case-control study recruited 379 BCa cases and 196 age-matched controls. The samples were genotyped for BRCA1 rs799917 (A/G) and rs1799966 (C/T) using TaqMan real-time polymerase chain reaction (PCR). Logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs). Allele frequencies from population-specific datasets in the database of single nucleotide polymorphism (dbSNP) were extracted and combined in a meta-analysis to compare variant distribution across global populations.ResultsNo significant association was observed between BRCA1 variants (rs799917 and rs1799966) and BCa risk in this cohort. Genotype distributions were comparable between cases and controls, and none of the tested genetic models reached statistical significance. Meta-analysis revealed marked inter-population variation in allele frequencies. Africans showed the lowest frequency of the rs799917 G allele (13.8%), and the highest frequency of the A allele (86.36%), whereas Europeans showed the highest G allele frequency (65.92%). For rs1799966, Africans had the lowest C allele frequency (20.17%) and highest T allele frequency (79.8%), while Asians showed the highest C frequency (38.25%).ConclusionBRCA1 variants rs79917 and rs1799966 were not associated with BCa susceptibility in this Nigerian cohort. The observed inter-population differences in allele frequencies highlight the importance of genetic diversity in understanding BCa risk.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.